🇺🇸 FDA
Drug

linvoseltamab-gcpt

Brand: LYNOZYFIC

approved

Quick answer

linvoseltamab-gcpt (LYNOZYFIC), is a pharmaceutical active ingredient, associated with enGene Therapeutics, with approved status in the US.

Key facts

INN
linvoseltamab-gcpt
Brand
LYNOZYFIC
Route
INJECTION
Formulation
SOLUTION
Originator
enGene Therapeutics

Frequently asked questions

What is linvoseltamab-gcpt?

linvoseltamab-gcpt (LYNOZYFIC), is a pharmaceutical active ingredient, associated with enGene Therapeutics, with approved status in the US.

What is the brand name for linvoseltamab-gcpt?

LYNOZYFIC is a marketed brand name for linvoseltamab-gcpt. Check FDA Drugs@FDA for the current US label holder.